NBTX Company Profile and Key Details

Q: Who are the executives of NBTX?

Mr. Earl J. Bergey Ph.d.Co-FounderMs. Kathryn M. McNeilSenior Vice President of Investor RelationsProf. Para Prasad Ph.D.Co-Founder and Member of Scientific BoardMr. Laurent Levy Ph.D.Co-Founder, Pres of the Executive Board & Chief Executive OfficerMr. Bart Van RhijnChief Financial Officer & Member of Executive BoardMr. Alain DostieChief Operating OfficerMs. Elsa BorghiHead of Innovation & Drug DiscoveryMs. Anne-Juliette Hermant M.A.Chief People Officer & Member of Executive BoardMs. Sarah GaubertHead of Communication & Public Affairs DepartmentMs. Margaret GalluzziVice President & Global Head of Clinical OperationsMr. Patrick Tricoli M.B.A., Pharm.D.Global Head of Bus. Devel.Mr. Ventzislav Vassilev M.D.Vice President & Global Head of Safety Vigilance

NASDAQ : NBTX

Nanobiotix SA

$39.52

0.63+1.62%

At Close 4:00 PM

62.39

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Nanobiotix S.A. (NBTX) stock surged +1.62%, trading at $39.52 on NASDAQ, up from the previous close of $38.89. The stock opened at $39.74, fluctuating between $38.91 and $40.26 in the recent session.

Stock Snapshot

38.89

Prev. Close

Market Cap

38.905

Day Low

-66.78

P/E Ratio

-0.59176

EPS (TTM)

-1.08

Cash Flow per Share

39.74

Open

50.6M

Number of Shares

40.26

Day High

79.98%

Free Float in %

-1.54

Book Value

90.99K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 04, 2026	40.26	40.26	38.91	39.52	91.6K
Aug 03, 2026	37.57	39.92	36.67	38.89	151.98K
Jul 31, 2026	40.07	40.07	38.01	38.39	129.99K
Jul 30, 2026	38.22	40.45	38.22	40.16	151.86K
Jul 29, 2026	37.52	38.52	36.90	37.85	176.6K
Jul 28, 2026	38.70	38.70	36.37	37.82	126.74K
Jul 27, 2026	39.93	40.85	39.33	40.18	95.21K
Jul 24, 2026	40.26	40.40	39.12	39.70	103.75K
Jul 23, 2026	39.50	40.63	38.00	39.55	153.06K
Jul 22, 2026	39.24	40.88	38.53	40.38	89.7K
Jul 21, 2026	36.37	39.84	36.37	39.42	131.83K
Jul 20, 2026	38.85	39.19	35.00	35.73	181.56K
Jul 17, 2026	36.16	38.38	36.12	37.79	218.73K
Jul 16, 2026	38.07	38.55	36.18	37.53	144.57K
Jul 15, 2026	40.23	42.00	39.25	39.96	104.56K
Jul 14, 2026	42.07	42.30	40.88	41.64	73.59K
Jul 13, 2026	39.95	40.52	38.74	39.15	106.9K
Jul 10, 2026	41.67	42.53	39.00	40.07	119.85K
Jul 09, 2026	38.89	39.57	38.74	38.95	39K
Jul 08, 2026	37.77	39.67	37.77	38.80	62.07K

Contact Details

Paris, IF 75012

France

https://www.nanobiotix.com 331 402 60470

About Company

Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma, various head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has established a strategic collaboration with LianBio for the development and commercialization of NBTXR3 within key Asian markets, specifically Greater China, South Korea, Singapore, and Thailand. Founded in 2003, the company's main operations are situated in Paris, France.

Stock Peers

ARGX

13.71+1.65%

argenx SE$844.50 REGN

1.42+0.19%

Regeneron Pharmaceuticals, Inc.$760.66 UTHR

2.37+0.46%

United Therapeutics Corporation$518.68 MDGL

25.56+5.30%

Madrigal Pharmaceuticals, Inc.$507.56 VRTX

7.985+1.70%

Vertex Pharmaceuticals Incorporated$478.71 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

12.2+3.90%

Krystal Biotech, Inc.$324.77 ONC

9.24+2.94%

BeOne Medicines AG$323.01 PRAX

4.56+1.49%

Praxis Precision Medicines, Inc.$310.07 LGND

8.75+3.00%

Ligand Pharmaceuticals Incorporated$300.79

Frequently Asked Questions

What is the current Nanobiotix S.A. (NBTX) stock price?

Nanobiotix S.A. (NASDAQ: NBTX) stock price is $39.52 in the last trading session. During the trading session, NBTX stock reached the peak price of $40.26 while $38.91 was the lowest point it dropped to. The percentage change in NBTX stock occurred in the recent session was 1.62% while the dollar amount for the price change in NBTX stock was $0.63.

NBTX's industry and sector of operation?

The NASDAQ listed NBTX is part of Biotechnology industry that operates in the broader Healthcare sector. Nanobiotix S.A. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NBTX?

Mr. Earl J. Bergey Ph.d.
Co-Founder
Ms. Kathryn M. McNeil
Senior Vice President of Investor Relations
Prof. Para Prasad Ph.D.
Co-Founder and Member of Scientific Board
Mr. Laurent Levy Ph.D.
Co-Founder, Pres of the Executive Board & Chief Executive Officer
Mr. Bart Van Rhijn
Chief Financial Officer & Member of Executive Board
Mr. Alain Dostie
Chief Operating Officer
Ms. Elsa Borghi
Head of Innovation & Drug Discovery
Ms. Anne-Juliette Hermant M.A.
Chief People Officer & Member of Executive Board
Ms. Sarah Gaubert
Head of Communication & Public Affairs Department
Ms. Margaret Galluzzi
Vice President & Global Head of Clinical Operations
Mr. Patrick Tricoli M.B.A., Pharm.D.
Global Head of Bus. Devel.
Mr. Ventzislav Vassilev M.D.
Vice President & Global Head of Safety Vigilance

How NBTX did perform over past 52-week?

NBTX's closing price is 472.84% higher than its 52-week low of $6.90 where as its distance from 52-week high of $57.14 is -30.84%.

How many employees does NBTX have?

Number of NBTX employees currently stands at 100.

Link for NBTX official website?

Official Website of NBTX is: https://www.nanobiotix.com

How do I contact NBTX?

NBTX could be contacted at phone 331 402 60470 and can also be accessed through its website. NBTX operates from 60 rue de Wattignies, Paris, IF 75012, France.

How many shares of NBTX are traded daily?

NBTX stock volume for the day was 90.99K shares. The average number of NBTX shares traded daily for last 3 months was 96.53K.

What is the market cap of NBTX currently?

The market value of NBTX currently stands at $2.00B with its latest stock price at $39.52 and 50.6M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	100
Beta	0.56
Sales or Revenue	$30.06M
5Y Sales Change%	3.612%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	100
Beta	0.56
Sales or Revenue	$30.06M
5Y Sales Change%	3.612%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

NBTX Company Profile and Key Details

Nanobiotix SA

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook